[1]
|
Ferraz, L.R.M., Santos, F.L.A., Ferreira, P.A., et al. (2014) Quality by Design in the Development and Validation of Analytical Method by Ultraviolet-Visible Spectrophotometry for Quantification of Hydroxychloroquine Sulfate. International Journal of Pharmaceutical Sciences and Research, 5, 4666.
|
[2]
|
Carr, R.E., Henkind, P., Rothfield, N. and Siegel, I.M. (1968) Ocular Toxicity of Antimalarial Drugs. American Journal of Ophthalmology, 66, 738-744. https://doi.org/10.1016/0002-9394(68)91300-7
|
[3]
|
Xu, C., Zhu, L., Chan, T., Lu, X., Shen, W., Madigan, M.C., et al. (2016) Chloroquine and Hydroxychloroquine Are Novel Inhibitors of Human Organic Anion Transporting Polypeptide 1A2. Journal of Pharmaceutical Sciences, 105, 884-890. https://doi.org/10.1002/jps.24663
|
[4]
|
Dongre, V.G., Ghugare, P.D., Karmuse, P., Singh, D., Jadhav, A. and Kumar, A. (2009) Identification and Characterization of Process Related Impurities in Chloroquine and Hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR. Journal of Pharmaceutical and Biomedical Analysis, 49, 873-879. https://doi.org/10.1016/j.jpba.2009.01.013
|
[5]
|
Koranda, F.C. (1981) Antimalarials. Journal of the American Academy of Dermatology, 4, 650-655. https://doi.org/10.1016/s0190-9622(81)70065-3
|
[6]
|
Mallhi, T.H., Ahmad, A., Butt, M.H., et al. (2020) Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals. Journal of College of Physicians and Surgeons Pakistan, 30, 124-128.
|
[7]
|
Akarsu, S. (2020) Hydroxychloroquine: From Pharmacological Profile to Neglected Adverse Reactions. The Journal of Basic and Clinical Health Sciences, 4, 205-211. https://doi.org/10.30621/jbachs.2020.1165
|
[8]
|
Shearer, R.V. and Dubois, E.L. (1967) Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) Therapy. American Journal of Ophthalmology, 64, 245-252. https://doi.org/10.1016/0002-9394(67)92518-4
|
[9]
|
Yusuf, I.H., Sharma, S., Luqmani, R. and Downes, S.M. (2017) Hydroxychloroquine Retinopathy. Eye, 31, 828-845. https://doi.org/10.1038/eye.2016.298
|
[10]
|
Marmor, M.F., Kellner, U., Lai, T.Y.Y., Melles, R.B. and Mieler, W.F. (2016) Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology, 123, 1386-1394. https://doi.o.rg/10.1016/j.ophtha.2016.01.058
|
[11]
|
Chen, Z., Hu, J., Zhang, Z., et al. (2020) Efficacy of Hydroxychloroquine in Patients with COVID-19: Results of a Randomized Clinical Trial.
|
[12]
|
Elavarasi, A., Prasad, M., Seth, T., Sahoo, R.K., Madan, K., Nischal, N., et al. (2020) Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Journal of General Internal Medicine, 35, 3308-3314. https://doi.org/10.1007/s11606-020-06146-w
|
[13]
|
Singh, A.K., Singh, A., Singh, R. and Misra, A. (2020) Hydroxychloroquine in Patients with COVID-19: A Systematic Review and Meta-Analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 589-596. https://doi.org/10.1016/j.dsx.2020.05.017
|
[14]
|
Farias, D.F., Souza, T., Souza, J.A.C.R., Vieira, L.R., Muniz, M.S., Martins, R.X., et al. (2020) COVID‐19 Therapies in Brazil: Should We Be Concerned with the Impacts on Aquatic Wildlife? Environmental Toxicology and Chemistry, 39, 2348-2350. https://doi.org/10.1002/etc.4888
|
[15]
|
Ben Ali, M., Hedfi, A., Almalki, M., Karachle, P.K. and Boufahja, F. (2021) Toxicity of Hydroxychloroquine, a Potential Treatment for COVID-19, on Free-Living Marine Nematodes. Marine Pollution Bulletin, 167, Article ID: 112361. https://doi.org/10.1016/j.marpolbul.2021.112361
|
[16]
|
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C.U. and Mohan, D. (2019) Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods. Chemical Reviews, 119, 3510-3673. https://doi.org/10.1021/acs.chemrev.8b00299
|
[17]
|
El Sharkasy, M.E., Tolba, M.M., Belal, F., Walash, M. and Aboshabana, R. (2022) Quantitative Analysis of Favipiravir and Hydroxychloroquine as FDA-Approved Drugs for Treatment of COVID‐19 Using Synchronous Spectrofluorimetry: Application to Pharmaceutical Formulations and Biological Fluids. Luminescence, 37, 953-964. https://doi.org/10.1002/bio.4240
|
[18]
|
Bodur, S., Erarpat, S., Günkara, Ö.T. and Bakırdere, S. (2021) Accurate and Sensitive Determination of Hydroxychloroquine Sulfate Used on COVID-19 Patients in Human Urine, Serum and Saliva Samples by GC-MS. Journal of Pharmaceutical Analysis, 11, 278-283. https://doi.org/10.1016/j.jpha.2021.01.006
|
[19]
|
Xiong, X., Wang, K., Tang, T., Fang, J. and Chen, Y. (2021) Development of a Chiral HPLC Method for the Separation and Quantification of Hydroxychloroquine Enantiomers. Scientific Reports, 11, Article No. 8017. https://doi.org/10.1038/s41598-021-87511-5
|
[20]
|
Qu, Y., Noe, G., Breaud, A.R., Vidal, M., Clarke, W.A., Zahr, N., et al. (2015) Development and Validation of a Clinical HPLC Method for the Quantification of Hydroxychloroquine and Its Metabolites in Whole Blood. Future Science OA, 1, FSO26. https://doi.org/10.4155/fso.15.24
|
[21]
|
Carvalho, M.S., Rocha, R.G., de Faria, L.V., Richter, E.M., Dantas, L.M.F., da Silva, I.S., et al. (2022) Additively Manufactured Electrodes for the Electrochemical Detection of Hydroxychloroquine. Talanta, 250, Article ID: 123727. https://doi.org/10.1016/j.talanta.2022.123727
|
[22]
|
Singh, A., Sharma, P.K., Gupta, R., et al. (2016) Development and Validation of UV-Spectrophotometric Method for the Estimation of Hydroxychloroquine Sulphate.
|
[23]
|
Ünal Taş, D. (2022) A New Method for Hydroxychloroquine Detection. Middle East Technical University.
|
[24]
|
Doğan, K., Ünal Taş, D., Persil Çetinkol, Ö. and Forough, M. (2024) Fluorometric and Colorimetric Platforms for Rapid and Sensitive Hydroxychloroquine Detection in Aqueous Samples. Talanta, 270, Article ID: 125523. https://doi.org/10.1016/j.talanta.2023.125523
|